What does this research mean for the field?

Biochemical, histologic, and mass changes in skeletal muscle are primary determinants of exercise intolerance in chronic heart failure, and these peripheral abnormalities can be therapeutically modified via ACE inhibitors, ARBs, and exercise training to improve functional capacity. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to investigate the relationship between skeletal muscle abnormalities and exercise intolerance in chronic heart failure patients.

May 1, 2003Congestive Heart FailureOpen Access

Skeletal Muscle Abnormalities in Chronic Heart Failure Patients: Relation to Exercise Capacity and Therapeutic Implications

View Full Paper

Ask AI

Bookmark

Why the study?

Do ACE inhibitors, ARBs, and exercise training improve skeletal muscle properties and exercise capacity in patients with chronic heart failure?

Population

Patients with chronic heart failure

Design

Review

Authors

INIlaria NicolettiOspedale San Bortolo MCMariantonietta CicoiraHeart Failure / Cardiomyopathy LZLuisa ZanollaUniversity of Verona

Discussion

Member takes

Implication

May support muscle-targeted therapy in chronic HF; leaves open confirmation in randomized outcome trials.

Key Points

The study aims to investigate the relationship between skeletal muscle abnormalities and exercise intolerance in chronic heart failure patients.
Evaluated biochemical and histologic changes in skeletal muscles of chronic heart failure patients.
Assessed exercise capacity and its correlation with muscle abnormalities.
Investigated the effects of medications and exercise training on muscle properties.
Biochemical and histologic muscle changes correlate significantly with exercise intolerance (p<0.01).
Reduction in skeletal muscle mass is a key factor influencing exercise capacity.
Administration of ACE inhibitors and ARBs leads to improvements in muscle properties and peak oxygen consumption.

Structured PICO

Do ACE inhibitors, ARBs, and exercise training improve skeletal muscle properties and exercise capacity in patients with chronic heart failure?

Population

Patients with chronic heart failure

Intervention

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and exercise training

Outcome

Exercise capacity and peak oxygen consumptionsurrogate

Skeletal muscle abnormalities are key drivers of exercise intolerance in chronic heart failure and represent a therapeutic target for ACE inhibitors, ARBs, and exercise training.

Cite This Study

Nicoletti et al. (2003) studied this question.

synapsesocial.com/papers/6a1d0185e19a8dd1302f1ef0 https://doi.org/10.1111/j.1527-5299.2002.01219.x

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Skeletal Muscle Abnormalities in Chronic Heart Failure Patients: Relation to Exercise Capacity and Therapeutic Implications

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Skeletal Muscle Abnormalities in Chronic Heart Failure Patients: Relation to Exercise Capacity and Therapeutic Implications

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider